Ketorine PF Eye Drops contain Ketorolac Tromethamine 0.4%, Fluorometholone 0.1%, and Polyvinyl Alcohol 1.4%, a triple-action ophthalmic formulation designed to treat ocular inflammation while providing lubrication and protection to the eye surface.
Ketorolac acts as a non-steroidal anti-inflammatory agent, Fluorometholone reduces ocular inflammation via steroidal action, and Polyvinyl Alcohol moisturizes and protects the ocular surface, providing comprehensive relief from irritation, redness, and discomfort.
From a commercial perspective, Ketorine PF Eye Drops are a high-demand ophthalmic anti-inflammatory-lubricant combination, widely used in eye hospitals, post-operative care, and specialty ophthalmology clinics, ensuring strong repeat prescriptions and steady demand.
Adding Ketorine PF Eye Drops to your portfolio strengthens the ophthalmic anti-inflammatory & lubricant segment, offering long-term growth, enhanced prescriber trust, and robust portfolio differentiation for PCD pharma franchise partners.